GINA RASNIC: Open Payments
NPI 1679924633 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$510 in 29 payments from 13 companies in 2025. Trend: 2023 $146 · 2024 $394 · 2025 $510
Food & beverage: $503Education: $7
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 9 | $145 |
| E.R. Squibb & Sons, L.L.C. | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $31 |
| Bausch Health US, LLC | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Corium, LLC | 3 | $24 |
| Tris Pharma Inc | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: HETLIOZ, COBENFY, REXULTI, TRINTELLIX, VRAYLAR, APLENZIN, Sunosi, Azstarys.
Industry payments across KS — which companies pay providers there.
